Viewing Study NCT04215159


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2025-12-25 @ 1:19 PM
Study NCT ID: NCT04215159
Status: UNKNOWN
Last Update Posted: 2020-01-02
First Post: 2019-09-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid Tumor
Sponsor: Jin-Hee Ahn
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module